HomeNDC LookupRxCUI directory › RxCUI 1550940

Colchicine 0.6 MG Oral Capsule — RxCUI 1550940

RxNorm drug concept · Semantic clinical drug
RxCUI 1550940 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 33 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1550940
Official nameColchicine 0.6 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped33
Reported Medicaid activity (SDUD)9,549 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Colchicine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most colchicine products — tablets, capsules, and the liquid Gloperba — are used to prevent gout flares in adults. Colcrys tablets and generic colchicine...
  • Diarrhea is the most common side effect and it's a real nuisance for many people. Colchicine affects the lining of the gut, and nausea, cramping, and loose stools often come with i...
  • Why does colchicine cause so much diarrhea?
  • This is one of the most important questions you can ask. Colchicine has some serious drug interactions that have caused deaths — not just discomfort. Certain antibiotics (like clar...
📖 Read our full Colchicine guide →

🕸️ Concept Web — How Colchicine 0.6 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Colchicine 0.6 MG Oral Capsule RxCUI 1550940

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Colchicine 2683
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mitigare 1550941
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Colchicine Oral Capsule 1550939
    • Colchicine Oral Product 1155484
    • Colchicine Pill 1155485
    • Colchicine Oral Capsule [Mitigare] 1550943
    • Mitigare Oral Product 1550944
    • Mitigare Pill 1550945
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Colchicine 0.6 MG SCDC · 315714
  • Colchicine Oral Capsule SCDF · 1550939
  • Colchicine Oral Product SCDG · 1155484
  • Colchicine Pill SCDG · 1155485

Brand-Name Concepts

  • Colchicine 0.6 MG Oral Capsule [Mitigare] SBD · 1550946
  • Colchicine 0.6 MG [Mitigare] SBDC · 1550942
  • Colchicine Oral Capsule [Mitigare] SBDF · 1550943
  • Mitigare Oral Product SBDG · 1550944
  • Mitigare Pill SBDG · 1550945
  • Mitigare BN · 1550941

📦 FDA Products & Package NDCs

13 products · 33 package NDCs
33 package NDCs map to RxCUI 1550940 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-3018-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-01) Colchicine Hikma Pharmaceuticals USA Inc. 2014-10-01
00143-3018-10 1000 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-10) Colchicine Hikma Pharmaceuticals USA Inc. 2014-10-01
00143-3018-30 30 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-30) Colchicine Hikma Pharmaceuticals USA Inc. 2018-07-23
00254-0460-01 100 CAPSULE in 1 BOTTLE (0254-0460-01) Colchicine Par Health USA, LLC 2023-11-01
00904-6732-04 30 BLISTER PACK in 1 CARTON (0904-6732-04) / 1 CAPSULE in 1... Colchicine Major Pharmaceuticals 2014-10-01
31722-0099-01 100 CAPSULE in 1 BOTTLE (31722-099-01) COLCHICINE Camber Pharmaceuticals, Inc. 2024-04-29
31722-0099-10 1000 CAPSULE in 1 BOTTLE (31722-099-10) COLCHICINE Camber Pharmaceuticals, Inc. 2024-04-29
31722-0099-30 30 CAPSULE in 1 BOTTLE (31722-099-30) COLCHICINE Camber Pharmaceuticals, Inc. 2024-04-29
42571-0341-01 100 CAPSULE in 1 BOTTLE (42571-341-01) Colchicine Micro Labs Limited 2026-02-18
42571-0341-10 1000 CAPSULE in 1 BOTTLE (42571-341-10) Colchicine Micro Labs Limited 2026-02-18
42571-0341-30 30 CAPSULE in 1 BOTTLE (42571-341-30) Colchicine Micro Labs Limited 2026-02-18
50090-3465-00 4 CAPSULE in 1 BOTTLE (50090-3465-0) Colchicine A-S Medication Solutions 2018-05-30
50090-3465-01 90 CAPSULE in 1 BOTTLE (50090-3465-1) Colchicine A-S Medication Solutions 2018-06-12
59467-0318-01 100 CAPSULE in 1 BOTTLE (59467-318-01) MITIGARE Hikma Specialty USA Inc. 2014-10-01
59467-0318-10 1000 CAPSULE in 1 BOTTLE (59467-318-10) MITIGARE Hikma Specialty USA Inc. 2014-10-01
59467-0318-30 30 CAPSULE in 1 BOTTLE (59467-318-30) MITIGARE Hikma Specialty USA Inc. 2018-07-26
59651-0446-01 100 CAPSULE in 1 BOTTLE (59651-446-01) Colchicine Aurobindo Pharma Limited 2024-04-29
59651-0446-30 30 CAPSULE in 1 BOTTLE (59651-446-30) Colchicine Aurobindo Pharma Limited 2024-07-01
59651-0446-99 1000 CAPSULE in 1 BOTTLE (59651-446-99) Colchicine Aurobindo Pharma Limited 2024-04-29
60687-0358-25 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-358-25) / 1 CAPS... Colchicine American Health Packaging 2018-04-04
67046-0889-03 30 CAPSULE in 1 BLISTER PACK (67046-0889-3) Colchicine Coupler LLC 2025-01-27
67046-1634-03 30 CAPSULE in 1 BLISTER PACK (67046-1634-3) COLCHICINE Coupler LLC 2025-12-30
70010-0001-01 100 CAPSULE in 1 BOTTLE (70010-001-01) Colchicine Granules Pharmaceutical Inc. 2024-04-29
70010-0001-03 30 CAPSULE in 1 BOTTLE (70010-001-03) Colchicine Granules Pharmaceutical Inc. 2024-08-22
70010-0001-10 1000 CAPSULE in 1 BOTTLE (70010-001-10) Colchicine Granules Pharmaceutical Inc. 2024-04-29
71335-2703-01 30 CAPSULE in 1 BOTTLE (71335-2703-1) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-02 10 CAPSULE in 1 BOTTLE (71335-2703-2) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-03 8 CAPSULE in 1 BOTTLE (71335-2703-3) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-04 90 CAPSULE in 1 BOTTLE (71335-2703-4) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-05 60 CAPSULE in 1 BOTTLE (71335-2703-5) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-06 3 CAPSULE in 1 BOTTLE (71335-2703-6) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-07 20 CAPSULE in 1 BOTTLE (71335-2703-7) Colchicine Bryant Ranch Prepack 2025-09-26
71335-2703-08 6 CAPSULE in 1 BOTTLE (71335-2703-8) Colchicine Bryant Ranch Prepack 2025-09-26
Observed labelers: Bryant Ranch Prepack (8) · Aurobindo Pharma Limited (3) · Camber Pharmaceuticals, Inc. (3) · Granules Pharmaceutical Inc. (3) · Hikma Pharmaceuticals USA Inc. (3) · Hikma Specialty USA Inc. (3) · +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.9555
Range $1.9555–$6.0351 · middle 50% $1.9555–$1.9555 · 16 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.